• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激光间质热疗治疗放射性坏死的组织学变化:病例说明

Histological changes associated with laser interstitial thermal therapy for radiation necrosis: illustrative cases.

作者信息

Fomchenko Elena I, Leelatian Nalin, Darbinyan Armine, Huttner Anita J, Chiang Veronica L

机构信息

Departments of1Neurosurgery and.

2Pathology, Yale School of Medicine, New Haven, Connecticut.

出版信息

J Neurosurg Case Lessons. 2022 Jul 4;4(1):CASE21373. doi: 10.3171/CASE21373.

DOI:10.3171/CASE21373
PMID:35855352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9257400/
Abstract

BACKGROUND

Patients with lung cancer and melanoma remain the two largest groups to develop brain metastases. Immunotherapy has been approved for treatment of stage IV disease in both groups. Many of these patients are additionally treated with stereotactic radiosurgery for their brain metastases during ongoing immunotherapy. Use of immunotherapy has been reported to increase the rates of radiation necrosis (RN) after radiosurgery, causing neurological compromise due to growth of the enhancing lesion as well as worsening of associated cerebral edema.

OBSERVATIONS

Laser interstitial thermal therapy (LITT) is a surgical approach that has been shown effective in the management of RN, especially given its efficacy in early reduction of perilesional edema. However, little remains known about the pathology of the post-LITT lesions and how LITT works in this condition. Here, we present two patients who needed surgical decompression after LITT for RN. Clinical, histopathological, and imaging features of both patients are presented.

LESSONS

Criteria for selecting the best patients with RN for LITT therapy remains unclear. Given two similarly sized lesions and not too dissimilar clinical histories but with differing outcomes, further investigation is clearly needed to identify predictors of response to LITT in the setting of SRS and immunotherapy-induced RN.

摘要

背景

肺癌和黑色素瘤患者仍是发生脑转移的两大主要群体。免疫疗法已被批准用于治疗这两类患者的IV期疾病。许多此类患者在进行免疫治疗期间,还因其脑转移接受了立体定向放射外科治疗。据报道,使用免疫疗法会增加放射外科治疗后放射性坏死(RN)的发生率,由于强化病灶的生长以及相关脑水肿的加重,导致神经功能受损。

观察结果

激光间质热疗(LITT)是一种手术方法,已被证明在治疗RN方面有效,特别是考虑到其在早期减轻病灶周围水肿方面的疗效。然而,关于LITT术后病变的病理学以及LITT在这种情况下的作用机制,人们了解甚少。在此,我们介绍两名在接受LITT治疗RN后需要手术减压的患者。展示了两名患者的临床、组织病理学和影像学特征。

经验教训

选择最适合接受LITT治疗的RN患者的标准仍不明确。鉴于两个大小相似且临床病史差异不大但结果不同的病灶,显然需要进一步研究以确定在立体定向放射外科和免疫疗法诱导的RN背景下对LITT反应的预测因素。

相似文献

1
Histological changes associated with laser interstitial thermal therapy for radiation necrosis: illustrative cases.激光间质热疗治疗放射性坏死的组织学变化:病例说明
J Neurosurg Case Lessons. 2022 Jul 4;4(1):CASE21373. doi: 10.3171/CASE21373.
2
A Single-Institution Retrospective Study of Patients Treated With Laser-Interstitial Thermal Therapy for Radiation Necrosis of the Brain.一项关于接受激光间质热疗法治疗脑放射性坏死患者的单机构回顾性研究。
Cureus. 2021 Nov 28;13(11):e19967. doi: 10.7759/cureus.19967. eCollection 2021 Nov.
3
Laser-interstitial thermal therapy compared to craniotomy for treatment of radiation necrosis or recurrent tumor in brain metastases failing radiosurgery.激光间质热疗与开颅手术治疗脑转移瘤放疗后坏死或复发的比较。
J Neurooncol. 2019 Apr;142(2):309-317. doi: 10.1007/s11060-019-03097-z. Epub 2019 Jan 17.
4
Time to Steroid Independence After Laser Interstitial Thermal Therapy vs Medical Management for Treatment of Biopsy-Proven Radiation Necrosis Secondary to Stereotactic Radiosurgery for Brain Metastasis.与药物治疗相比,激光间质热疗治疗经活检证实的脑转移瘤立体定向放射治疗后继发放射性坏死实现停用类固醇的时间
Neurosurgery. 2022 Jun 1;90(6):684-690. doi: 10.1227/neu.0000000000001922. Epub 2022 Mar 23.
5
Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.立体定向放射外科后激光消融:转移性脑肿瘤和放射性坏死患者的多中心前瞻性研究。
J Neurosurg. 2019 Mar 1;130(3):804-811. doi: 10.3171/2017.11.JNS171273. Epub 2018 May 4.
6
Efficacy of laser interstitial thermal therapy for biopsy-proven radiation necrosis in radiographically recurrent brain metastases.激光间质热疗对经活检证实的影像学复发性脑转移瘤放射性坏死的疗效。
Neurooncol Adv. 2023 Mar 28;5(1):vdad031. doi: 10.1093/noajnl/vdad031. eCollection 2023 Jan-Dec.
7
Predictors of Local Control of Brain Metastasis Treated With Laser Interstitial Thermal Therapy.激光间质热疗治疗脑转移瘤局部控制的预测因素。
Neurosurgery. 2020 Jul 1;87(1):112-122. doi: 10.1093/neuros/nyz357.
8
Laser interstitial thermal therapy for in-field recurrence of brain metastasis after stereotactic radiosurgery: does treatment with LITT prevent a neurologic death?立体定向放射治疗后脑转移瘤瘤内复发的激光间质热疗:LITT 治疗是否能预防神经死亡?
Clin Exp Metastasis. 2020 Jun;37(3):435-444. doi: 10.1007/s10585-020-10035-1. Epub 2020 May 6.
9
Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis.贝伐单抗对比激光间质热疗治疗脑转移瘤放射性坏死:一项系统评价和荟萃分析。
J Neurooncol. 2021 Aug;154(1):13-23. doi: 10.1007/s11060-021-03802-x. Epub 2021 Jul 3.
10
Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases.激光间质热疗(LITT)与贝伐单抗治疗放射性脑转移瘤放射性坏死的比较。
J Neurooncol. 2020 Jul;148(3):641-649. doi: 10.1007/s11060-020-03570-0. Epub 2020 Jun 29.

引用本文的文献

1
Safety and Efficacy of Laser Interstitial Thermal Therapy as Upfront Therapy in Primary Glioblastoma and IDH-Mutant Astrocytoma: A Meta-Analysis.激光间质热疗作为原发性胶质母细胞瘤和异柠檬酸脱氢酶(IDH)突变型星形细胞瘤一线治疗的安全性和有效性:一项荟萃分析
Cancers (Basel). 2024 Jun 3;16(11):2131. doi: 10.3390/cancers16112131.

本文引用的文献

1
Characterization of the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma Using Imaging Mass Cytometry.利用成像质谱流式细胞术对肺鳞状细胞癌肿瘤免疫微环境进行表征
Front Oncol. 2021 Apr 1;11:620989. doi: 10.3389/fonc.2021.620989. eCollection 2021.
2
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.高 PD-L1 表达的非小细胞肺癌伴脑转移患者,帕博利珠单抗引起免疫相关不良反应后生存和疾病控制得到改善。
J Neurooncol. 2021 Mar;152(1):125-134. doi: 10.1007/s11060-020-03686-3. Epub 2021 Jan 7.
3
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
辅助纳武利尤单抗对比伊匹单抗用于可切除 IIIB-C 期和 IV 期黑色素瘤(CheckMate 238 研究):一项多中心、双盲、随机、对照、III 期临床试验的 4 年结果。
Lancet Oncol. 2020 Nov;21(11):1465-1477. doi: 10.1016/S1470-2045(20)30494-0. Epub 2020 Sep 19.
4
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells.脑肿瘤微环境景观的剖析揭示了免疫细胞的疾病特异性改变。
Cell. 2020 Jun 25;181(7):1643-1660.e17. doi: 10.1016/j.cell.2020.05.007. Epub 2020 May 28.
5
Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study.针对脑转移非小细胞肺癌患者,立体定向放射外科联合或不联合检查点抑制治疗:一项匹配队列研究。
J Neurosurg. 2019 Jul 26;133(3):685-692. doi: 10.3171/2019.4.JNS19822. Print 2020 Sep 1.
6
Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma.免疫检查点抑制剂伊匹单抗治疗转移性黑色素瘤的预后生物标志物。
Clin Exp Immunol. 2019 Jul;197(1):74-82. doi: 10.1111/cei.13283. Epub 2019 Mar 21.
7
Histologic findings associated with laser interstitial thermotherapy for glioblastoma multiforme.与多形性胶质母细胞瘤的激光间质热疗相关的组织学发现。
Diagn Pathol. 2019 Feb 15;14(1):19. doi: 10.1186/s13000-019-0794-4.
8
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.纳武利尤单抗联合伊匹单抗或纳武利尤单抗单药对比伊匹单抗单药治疗晚期黑色素瘤(CheckMate 067):一项多中心、随机、III 期临床试验的 4 年结果。
Lancet Oncol. 2018 Nov;19(11):1480-1492. doi: 10.1016/S1470-2045(18)30700-9. Epub 2018 Oct 22.
9
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.新辅助免疫检查点阻断治疗高危可切除黑色素瘤。
Nat Med. 2018 Nov;24(11):1649-1654. doi: 10.1038/s41591-018-0197-1. Epub 2018 Oct 8.
10
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).癌症免疫治疗学会关于免疫治疗非小细胞肺癌(NSCLC)的共识声明。
J Immunother Cancer. 2018 Jul 17;6(1):75. doi: 10.1186/s40425-018-0382-2.